| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors
|
Boleti, E.
|
|
|
18 |
2 |
p. 376-380
|
artikel
|
| 2 |
A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
|
Nitta, E.
|
|
|
18 |
2 |
p. 364-369
|
artikel
|
| 3 |
Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis
|
Grunberg, S.M.
|
|
|
18 |
2 |
p. 233-240
|
artikel
|
| 4 |
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
|
Fischer, B.M.
|
|
|
18 |
2 |
p. 338-345
|
artikel
|
| 5 |
Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
|
Sanna, G.
|
|
|
18 |
2 |
p. 288-292
|
artikel
|
| 6 |
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
|
Trédan, O.
|
|
|
18 |
2 |
p. 256-262
|
artikel
|
| 7 |
Components of the metabolic syndrome in long-term survivors of testicular cancer
|
Haugnes, H.S.
|
|
|
18 |
2 |
p. 241-248
|
artikel
|
| 8 |
Dietary intake of fruit and vegetable and lung cancer risk: a case–control study in Harbin, northeast China
|
Galeone, C.
|
|
|
18 |
2 |
p. 388-392
|
artikel
|
| 9 |
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
|
Comella, P.
|
|
|
18 |
2 |
p. 324-330
|
artikel
|
| 10 |
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged ≥70 years with advanced ovarian cancer—a study by the AGO OVAR Germany
|
Hilpert, F.
|
|
|
18 |
2 |
p. 282-287
|
artikel
|
| 11 |
Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndrome
|
de Haas, E.C.
|
|
|
18 |
2 |
p. 211-212
|
artikel
|
| 12 |
Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
|
Arnaud, P.
|
|
|
18 |
2 |
p. 400-401
|
artikel
|
| 13 |
Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
|
Rubbia-Brandt, L.
|
|
|
18 |
2 |
p. 299-304
|
artikel
|
| 14 |
International Association for Hospice and Palliative Care list of essential medicines for palliative care
|
De Lima, L.
|
|
|
18 |
2 |
p. 395-399
|
artikel
|
| 15 |
in this issue
|
|
|
|
18 |
2 |
p. 209
|
artikel
|
| 16 |
Is carboplatin–paclitaxel combination the standard treatment of elderly ovarian cancer patients?
|
Zola, P.
|
|
|
18 |
2 |
p. 213-214
|
artikel
|
| 17 |
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?
|
Di Raimondo, F.
|
|
|
18 |
2 |
p. 351-356
|
artikel
|
| 18 |
Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer
|
Younis, T.
|
|
|
18 |
2 |
p. 293-298
|
artikel
|
| 19 |
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
|
Parmiani, G.
|
|
|
18 |
2 |
p. 226-232
|
artikel
|
| 20 |
Phase II studies of anticancer chemotherapy: indirect evidence of poor quality
|
Ottaiano, A.
|
|
|
18 |
2 |
p. 403
|
artikel
|
| 21 |
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
|
van Luijk, I.F.
|
|
|
18 |
2 |
p. 275-281
|
artikel
|
| 22 |
Phase II study of gemcitabine–dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
|
Morschhauser, F.
|
|
|
18 |
2 |
p. 370-375
|
artikel
|
| 23 |
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
|
Souglakos, J.
|
|
|
18 |
2 |
p. 305-310
|
artikel
|
| 24 |
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
|
Rocha-Lima, C.M.
|
|
|
18 |
2 |
p. 331-337
|
artikel
|
| 25 |
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
|
Klimm, B.
|
|
|
18 |
2 |
p. 357-363
|
artikel
|
| 26 |
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
|
Arcaini, L.
|
|
|
18 |
2 |
p. 346-350
|
artikel
|
| 27 |
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
|
Choueiri, T.K.
|
|
|
18 |
2 |
p. 249-255
|
artikel
|
| 28 |
Prognostic significance of stromal versican expression in human endometrial cancer
|
Kodama, J.
|
|
|
18 |
2 |
p. 269-274
|
artikel
|
| 29 |
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
|
Ohe, Y.
|
|
|
18 |
2 |
p. 317-323
|
artikel
|
| 30 |
Rasburicase-induced fatal respiratory arrest?
|
Trujillo, M.
|
|
|
18 |
2 |
p. 399-400
|
artikel
|
| 31 |
Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer
|
Liu, Y.
|
|
|
18 |
2 |
p. 311-316
|
artikel
|
| 32 |
Reply to the article ‘Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)’ by P. Arnaud, M.-C. Escande, M. Lecuit et al. (Ann Oncol doi:10.1093/annonc/mdl369)
|
Ferreri, A.J.M.
|
|
|
18 |
2 |
p. 401-403
|
artikel
|
| 33 |
Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery
|
Cardillo, A.
|
|
|
18 |
2 |
p. 394-395
|
artikel
|
| 34 |
Second consensus on medical treatment of metastatic breast cancer
|
Beslija, S.
|
|
|
18 |
2 |
p. 215-225
|
artikel
|
| 35 |
Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
|
Ferrero, J.-M.
|
|
|
18 |
2 |
p. 263-268
|
artikel
|
| 36 |
Suicide and cancer: a gender-comparative study
|
Kendal, W.S.
|
|
|
18 |
2 |
p. 381-387
|
artikel
|
| 37 |
Table of Contents
|
|
|
|
18 |
2 |
p. iv-vi
|
artikel
|
| 38 |
The cost-effectiveness of bisphosphonates in metastatic breast cancer: letter to the editor in response to Botteman et al. 2006
|
Souberbielle, B.
|
|
|
18 |
2 |
p. 393
|
artikel
|
| 39 |
What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?
|
Mandalà, M.
|
|
|
18 |
2 |
p. 404
|
artikel
|
Tijdschrift beschrijving